494 related items for PubMed ID: 17625985
1. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
Miller CJ, Senn S, Mezzanotte WS.
Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
[Abstract] [Full Text] [Related]
2. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J, Huchon G, Leclerc V, Vicaut E, Lefrançois G.
Respiration; 2005 Mar; 72 Suppl 1():6-12. PubMed ID: 15915007
[Abstract] [Full Text] [Related]
3. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
[Abstract] [Full Text] [Related]
4. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
Hampel FC, Martin P, Mezzanotte WS.
J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
[Abstract] [Full Text] [Related]
5. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE, Noonan MJ.
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[Abstract] [Full Text] [Related]
6. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
Drugs; 2006 May; 66(17):2235-54. PubMed ID: 17137405
[Abstract] [Full Text] [Related]
7. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D, Vicaut E, Lefrançois G, Formoterol HFA group.
Respiration; 2005 May; 72 Suppl 1():20-7. PubMed ID: 15915009
[Abstract] [Full Text] [Related]
8. Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults.
Eklund A, Tronde A, Johannes-Hellberg I, Gillen M, Borgström L.
Biopharm Drug Dispos; 2008 Oct; 29(7):382-95. PubMed ID: 18623040
[Abstract] [Full Text] [Related]
9. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
[Abstract] [Full Text] [Related]
10. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O'Dowd L.
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
[Abstract] [Full Text] [Related]
11. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M.
Drugs; 2008 Nov; 68(14):1975-2000. PubMed ID: 18778120
[Abstract] [Full Text] [Related]
12. Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma.
Morice AH, Hochmuth L, Ekelund J, Thorén A, Puterman AS.
Pulm Pharmacol Ther; 2008 Nov; 21(1):32-9. PubMed ID: 17118686
[Abstract] [Full Text] [Related]
13. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
Molimard M, Guenolé E, Duvauchelle T, Vicaut E, Lefrançois G.
Respiration; 2005 Nov; 72 Suppl 1():28-34. PubMed ID: 15915010
[Abstract] [Full Text] [Related]
14. Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma.
Morice AH, Peterson S, Beckman O, Osmanliev D.
Int J Clin Pract; 2007 Nov; 61(11):1874-83. PubMed ID: 17887990
[Abstract] [Full Text] [Related]
15. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS.
Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
[Abstract] [Full Text] [Related]
16. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
Kerwin EM, Oppenheimer JJ, LaForce C, Parasuraman B, Miller CJ, O'Dowd L, Goldman M.
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
[Abstract] [Full Text] [Related]
17. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
Tronde A, Gillen M, Borgström L, Lötvall J, Ankerst J.
J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
[Abstract] [Full Text] [Related]
18. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE.
Drugs; 2009 Nov; 69(5):549-65. PubMed ID: 19368417
[Abstract] [Full Text] [Related]
19. Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma.
Korenblat PE, Rosenwasser LJ.
Allergy Asthma Proc; 2010 Nov; 31(3):190-202. PubMed ID: 20482961
[Abstract] [Full Text] [Related]
20. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
Berger WE, Gillen M, Eckerwall G, Uryniak T, Trudo FJ, Lampl KL.
Allergy Asthma Proc; 2014 Nov; 35(2):134-40. PubMed ID: 24717790
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]